What is Phenylketonuria (PKU) Screening?
Phenylketonuria (PKU) Screening is a newborn screening test used to identify babies who may have phenylketonuria (PKU), a rare inherited metabolic disorder that affects the body’s ability to process the amino acid phenylalanine. PKU occurs when the body does not produce enough of the enzyme needed to break down phenylalanine, which is found in protein-containing foods and certain artificial sweeteners. As a result, phenylalanine can build up in the blood and cause damage to the brain if the condition is not treated.
Early detection through Phenylketonuria (PKU) Screening allows treatment to begin before symptoms develop. Management commonly involves a carefully controlled diet that limits phenylalanine intake and regular monitoring of blood phenylalanine levels. PKU is usually detected as part of routine newborn screening programs.
How is the Test Performed?
Preparation
- Preparing for Phenylketonuria (PKU) Screening is generally straightforward.
- The test is usually performed after the newborn has started feeding.
- The sample is typically collected between 24 and 48 hours after birth, depending on local newborn screening guidelines.
- Inform the healthcare provider if the baby was born prematurely or received a blood transfusion, as additional testing may be required.
Collection
- The test requires a small blood sample from the newborn’s heel.
- The baby’s heel is gently warmed and cleaned.
- A healthcare professional makes a small prick on the heel.
- A few drops of blood are placed onto a special filter paper card.
- The sample is dried and sent to the laboratory for analysis.
- The procedure is quick and may cause brief discomfort for the newborn.
Lab Analysis
The dried blood spot is analyzed to measure phenylalanine levels and, depending on the screening program, other markers associated with PKU and related metabolic disorders. Screening results identify babies who may be at increased risk and require confirmatory testing. A positive screening result does not by itself confirm PKU; additional diagnostic testing is required.
What are the Symptoms that Prompt this Screening?
Phenylketonuria (PKU) Screening is primarily performed as a routine newborn screening test because babies with PKU usually have no symptoms at birth. Early screening is important because untreated PKU can cause serious health and developmental problems.
Symptoms and Situations That May Prompt This Screening
Although newborns are usually screened before symptoms appear, signs that may develop in an untreated child include:
- Developmental delays
- Intellectual disability
- Seizures
- Behavioral problems
- Eczema or skin rashes
- Musty or unusual body odor
- Lighter skin, hair, or eye color than other family members
- Difficulty with growth and development
Conditions That May Require This Screening
Phenylketonuria (PKU) Screening may be performed for:
- Routine newborn screening
- Family history of PKU
- A previous child diagnosed with PKU
- A newborn who missed initial screening
- A newborn who requires repeat screening due to premature birth or other factors
- Follow-up after an abnormal newborn screening result
What are Normal Ranges for This Screening?
The Phenylketonuria (PKU) screening normal range is based primarily on the amount of phenylalanine (Phe) detected in the newborn’s blood.
Screening results may generally be reported as:
Normal/Negative: Phenylalanine levels are below the laboratory’s screening cutoff, indicating a low likelihood of PKU. Normal Phe levels are below 2 mg/dL.
Abnormal/Positive: Phenylalanine levels are higher than the screening cutoff, indicating that additional testing is needed. Abnormal Phe levels are above 4 mg/dL.
The exact cutoff values can vary depending on the newborn’s age when the sample was collected, the laboratory method used, and the screening program.
“The reference ranges vary depending on the laboratory and the methodology used. Individuals must consult their healthcare provider for correct interpretation of the results.”
What Happens if Test Results Show Abnormal Findings?
An abnormal Phenylketonuria (PKU) Screening result does not necessarily mean that a baby has PKU. It indicates that the phenylalanine level was higher than the screening cutoff and that further testing is needed.
High Phenylalanine Levels
Elevated phenylalanine levels may be associated with:
- Phenylketonuria (PKU)
- Mild or moderate hyperphenylalaninemia
- Other metabolic disorders affecting phenylalanine metabolism
If PKU is confirmed and treatment is not started, high phenylalanine levels can cause:
- Intellectual disability
- Developmental delays
- Seizures
- Behavioral and neurological problems
- Brain damage
If the screening result is abnormal, the healthcare provider may recommend additional investigations such as:
- Quantitative blood phenylalanine testing
- Plasma amino acid testing
- Genetic testing for PAH gene mutations
- Additional metabolic testing
Normal Phenylalanine Levels
A normal screening result generally means that the baby is unlikely to have PKU. However, screening tests cannot detect every case, and repeat or diagnostic testing may sometimes be necessary based on clinical concerns or family history.
If PKU is confirmed, treatment typically involves a specialized diet that restricts phenylalanine while providing adequate nutrition for normal growth and development. Ongoing monitoring of blood phenylalanine levels is also important.
Need Phenylketonuria (PKU) Screening? Book your appointment today for reliable newborn screening and expert laboratory support.
